Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Murine thrombosis models.
Day SM, Reeve JL, Myers DD, Fay WP. Day SM, et al. Thromb Haemost. 2004 Sep;92(3):486-94. Thromb Haemost. 2004. PMID: 15351844
Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
Tilley RE, Pedersen B, Pawlinski R, Sato Y, Erlich JH, Shen Y, Day S, Huang Y, Eitzman DT, Boisvert WA, Curtiss LK, Fay WP, Mackman N. Tilley RE, et al. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):555-62. doi: 10.1161/01.ATV.0000202028.62414.3c. Epub 2005 Dec 29. Arterioscler Thromb Vasc Biol. 2006. PMID: 16385085
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy.
Butters A, Arnott C, Sweeting J, Claggett B, Cuomo A, Abrams D, Ashley EA, Day SM, Helms AS, Lampert R, Lin K, Michels M, Miller EM, Olivotto I, Owens A, Parikh VN, Pereira AC, Rossano JW, Ryan TD, Saberi S, Stendahl JC, Ware JS, Atherton J, Semsarian C, Lakdawala NK, Ho CY, Ingles J. Butters A, et al. Among authors: day sm. Circ Genom Precis Med. 2025 Jan 24:e004641. doi: 10.1161/CIRCGEN.124.004641. Online ahead of print. Circ Genom Precis Med. 2025. PMID: 39851041
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.
Meisner JK, Renberg A, Smith ED, Tsan YC, Elder B, Bullard A, Merritt O, Zheng SL, Lakdawala N, Owens A, Ryan TD, Miller EM, Rossano J, Lin KY, Claggett B, Ashley E, Michels M, Lampert R, Stendahl JC, Abrahams D, Semsarian C, Parikh VN, Wheeler M, Ingles J, Day SM, Saberi S, Russell MW, Previs M, Ho C, Ware JS, Helms AS. Meisner JK, et al. Among authors: day sm. Circulation. 2024 Dec 5. doi: 10.1161/CIRCULATIONAHA.124.069398. Online ahead of print. Circulation. 2024. PMID: 39633578
Centennial Collection: Hypertrophic Cardiomyopathy.
Day SM. Day SM. Circulation. 2024 Oct 29;150(18):1395-1397. doi: 10.1161/CIRCULATIONAHA.124.070134. Epub 2024 Oct 28. Circulation. 2024. PMID: 39466888 Free article. No abstract available.
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
Maurizi N, Antiochos P, Owens A, Lakdwala N, Saberi S, Russell MW, Fumagalli C, Skalidis I, Lin KY, Nathan AS, De Feria Alsina A, Reza N, Stendahl JC, Abrams D, Semsarian C, Clagget B, Lampert R, Wheeler M, Parikh VN, Ashley E, Michels M, Rossano J, Ryan TD, Ingles J, Ware J, Ho CY, Helms AS, Day SM, Olivotto I. Maurizi N, et al. Among authors: day sm. Circulation. 2024 Oct 22;150(17):1377-1390. doi: 10.1161/CIRCULATIONAHA.124.069378. Epub 2024 Oct 2. Circulation. 2024. PMID: 39355918
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.
Ireland CG, Burstein DS, Day SM, Axelsson Raja A, Russell MW, Zahka KG, Pereira A, Canter CE, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Soslow JH, Becker JR, Giverts I, Orav EJ, Claggett B, Lin KY, Ho CY. Ireland CG, et al. Among authors: day sm. Circ Heart Fail. 2024 Aug;17(8):e011663. doi: 10.1161/CIRCHEARTFAILURE.124.011663. Epub 2024 Aug 1. Circ Heart Fail. 2024. PMID: 39087355 Review.
213 results